| Name | Title | Contact Details |
|---|
Vikor Scientific is a molecular diagnostics company based in Charleston, South Carolina. The company specializes in targeted molecular pathogen detection and antibiotic resistance gene testing. Their advanced diagnostic solutions aim to improve clinical and economic outcomes in healthcare by enabling rapid and accurate identification of infectious agents and resistance genes. Vikor Scientific offers an extensive Resistance Gene Testing Panel that can identify up to 49 resistance genes, including those linked to extended-spectrum beta-lactamases (ESBL). Their testing panels are customized for various body systems and cover most pathogens associated with infections in the U.S. Utilizing molecular techniques, Vikor Scientific detects DNA and RNA sequences directly from patient samples, allowing for quick and precise pathogen identification. Test results are delivered electronically through a HIPAA-compliant portal, ensuring timely access for healthcare providers. With around 248 employees and annual revenue of approximately $61 million, Vikor Scientific is recognized as a leader in molecular diagnostics, particularly in rapid pathogen detection and antibiotic resistance testing. Their mission focuses on delivering precise diagnostics that enhance patient outcomes and promote effective antibiotic use.
Bieri Hearing Clinic is a Midland, MI-based company in the Business Services sector.
C & S Payroll Services is a Roswell, GA-based company in the Business Services sector.
HUK 24 is a Coburg, AK-based company in the Business Services sector.
EnfraGen is a developer, owner, and operator of grid stability and value-added renewable energy infrastructure businesses across Latin American investment-grade countries. EnfraGens grid stability assets supply flexible capacity and energy to local and regional grids in support of renewable power plant intermittent energy production. EnfraGens renewable plants are smaller scale, distributed solar photovoltaic and hydroelectric assets that take advantage of unique access points to electrical infrastructure or are located in optimized geographical locations. The business mission is to support the transition to zero-carbon emission electric grids. EnfraGen is jointly controlled by Glenfarne Group, LLC, and global private markets investment manager Partners Group, on behalf of its clients, and has operational and in-construction assets across its subsidiaries totaling over 1.7GW of installed capacity in operation. The company, including its affiliates and subsidiaries, is supported by a team of approximately 325 professionals. EnfraGen maintains offices and assets in Chile, Panama, Colombia, and the United States.